U.S. Pharmacist Weekly News Update
January 22, 2020

FDA New-Medication Approval Times Dropped Significantly in Recent Years

The FDA is approving new medications more quickly and authorizing use of more generic drugs and biologics, according to a new review. Find out how and why this is occurring, based on a look-back at approvals since the 1980s.


New Assessment of Fluoroquinolone Prescribing
in LTC Patients

How many of the fluoroquinolone antibiotic scripts being filled for long-term care (LTC) patients are inappropriate? A new study suggests that a lot of them are, pointing out that numerous precautions apparently are being overlooked when the antibiotics are prescribed. 

Three New York C Auris
Patients Pan-Resistant to
Antifungal Treatment

Hospital pharmacists should be on the lookout for inpatient yeast infections that don’t respond to routine anti-fungal medications. Three pan-resistant Candida auris cases were recently identified in New York. Here is more information.

Does Long-Term Estrogen Exposure Improve Mental Status in Older Women?
For years, women have been cautioned about the potential dangers of long-term hormone therapy. Find out why a new study suggests long-term hormone therapy, as well as lengthier endogenous estrogen exposure, can be helpful in maintaining cognitive status in older, postmenopausal women.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App